Valuation mark-downs appear to have become the flavour of the season. Amid issues of corporate governance, layoffs and more, the news of another start-up’s valuation getting slashed shouldn’t be ...

As the festive dust settles, can quick service platforms convert seasonal users into loyalists without burning billions in ...

Indian online pharmacy startup PharmEasy is planning to raise about $300 million in a new round of funding at a 90% markdown from the previous valuation, two people familiar with the matter said, ...

Distressed healthtech startup PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% ...

In a notable pivot from healthcare to home improvement, PharmEasy co-founders Dharmil Sheth, Dhaval Shah, and Hardik Dedhia have launched All Home, a new venture aimed at organizing India's fragmented ...

The company has now become the largest healthcare delivery platform across the country, catering to more than two million families every single month, PharmEasy said. "This acquisition significantly ...

Janus Henderson, a top investor in Pharmeasy, has slashed the healthtech firm's valuation to $2.8 billion. This is the second markdown in the valuation of the e-pharmacy this year. Last week, US ...

PharmEasy, which acquired diagnostic chain Thyrocare, has raised $300 million from its existing investors. The funding will be used for the ongoing acquisition process of Thyrocare. Once the deal is ...

Mumbai: Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year's $5.1 billion, two ...

API Holdings, which operates the giant healthcare startup PharmEasy, said on Friday it has reached an agreement to acquire a 66.1% stake in Thyrocare, which runs a diagnostic lab chain, for about $613 ...